Treatment of infections caused by carbapenemase-producing Enterobacterales
Rev. esp. quimioter
; 35(Supl. 3): 46-50, Oct. 2022. tab
Article
em En
| IBECS
| ID: ibc-210748
Biblioteca responsável:
ES1.1
Localização: ES15.1 - BNCS
ABSTRACT
Antibiotic resistance is one of the main menaces to public and individual health worldwide. In the last two decades, an increase in the detection of arbapenem-resistant Enterobacterales has been reported. The treatment of infections caused by these strains is a therapeutic challenge. The use of carbapenems may be beneficial depending on MIC value and source of infection. New drugs, with different activity against the different classes of carbapenemases, are developed showing significant benefits. (AU)
Palavras-chave
Texto completo:
1
Coleções:
06-national
/
ES
Base de dados:
IBECS
Assunto principal:
Resistência Microbiana a Medicamentos
/
Enterobacteriáceas Resistentes a Carbapenêmicos
Limite:
Humans
Idioma:
En
Revista:
Rev. esp. quimioter
Ano de publicação:
2022
Tipo de documento:
Article